Liyong Yang

Fuzhou, 350005, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

TLR4 mediates lipotoxic β-cell dysfunction by inhibiting the TMEM24/PI3K/AKT pathway.

TLR4 mediates lipotoxic β-cell dysfunction by inhibiting the TMEM24/PI3K/AKT pathway.

Journal: Acta biochimica et biophysica Sinica

Published: April 02, 2025

Glucotoxicity Activation of IL6 and IL11 and Subsequent Induction of Fibrosis May Be Involved in the Pathogenesis of Islet Dysfunction.

Glucotoxicity Activation of IL6 and IL11 and Subsequent Induction of Fibrosis May Be Involved in the Pathogenesis of Islet Dysfunction.

Journal: Frontiers in molecular biosciences

Published: May 11, 2021

Composite cardiovascular risk and BMI affected comparative profiles of BIAsp 30 + metformin vs BIAsp 30 monotherapy: a MERIT post-hoc analysis.

Composite cardiovascular risk and BMI affected comparative profiles of BIAsp 30 + metformin vs BIAsp 30 monotherapy: a MERIT post-hoc analysis.

Journal: Scientific reports

Published: November 06, 2020

Glucagon-like peptide-1 receptor pathway inhibits extracellular matrix production by mesangial cells through store-operated Ca2+ channel.

Glucagon-like peptide-1 receptor pathway inhibits extracellular matrix production by mesangial cells through store-operated Ca2+ channel.

Journal: Experimental biology and medicine (Maywood, N.J.)

Published: September 13, 2019

Exendin‑4 inhibits lipotoxicity‑induced oxidative stress in β‑cells by inhibiting the activation of TLR4/NF‑κB signaling pathway.

Exendin‑4 inhibits lipotoxicity‑induced oxidative stress in β‑cells by inhibiting the activation of TLR4/NF‑κB signaling pathway.

Journal: International journal of molecular medicine

Published: May 29, 2019

Metformin Reduces Lipotoxicity-Induced Meta-Inflammation in β-Cells through the Activation of GPR40-PLC-IP3 Pathway.

Metformin Reduces Lipotoxicity-Induced Meta-Inflammation in β-Cells through the Activation of GPR40-PLC-IP3 Pathway.

Journal: Journal of diabetes research

Published: May 15, 2019

TAK-875 Mitigates β-Cell Lipotoxicity-Induced Metaflammation Damage through Inhibiting the TLR4-NF-κB Pathway.

TAK-875 Mitigates β-Cell Lipotoxicity-Induced Metaflammation Damage through Inhibiting the TLR4-NF-κB Pathway.

Journal: Journal of diabetes research

Published: May 05, 2019

TLR4 knockout can improve dysfunction of β-cell by rebalancing proteomics disorders in pancreas of obese rats.

TLR4 knockout can improve dysfunction of β-cell by rebalancing proteomics disorders in pancreas of obese rats.

Journal: Endocrine

Published: May 04, 2019

Different expression profile of mRNA and long noncoding RNA in autoimmune thyroid diseases patients.

Different expression profile of mRNA and long noncoding RNA in autoimmune thyroid diseases patients.

Journal: Journal of cellular biochemistry

Published: January 21, 2019

Observational study evaluating the effectiveness of physician-targeted education for improving glycemic management of patients with type 2 diabetes (BEYOND II).

Observational study evaluating the effectiveness of physician-targeted education for improving glycemic management of patients with type 2 diabetes (BEYOND II).

Journal: Journal of diabetes

Published: January 04, 2019

Identification of key genes involved in type 2 diabetic islet dysfunction: a bioinformatics study.

Identification of key genes involved in type 2 diabetic islet dysfunction: a bioinformatics study.

Journal: Bioscience reports

Published: November 24, 2018

Standards of medical care for type 2 diabetes in China 2019.

Standards of medical care for type 2 diabetes in China 2019.

Journal: Diabetes/metabolism research and reviews

Published: November 07, 2018

Showing 1-12 of 28

Last Updated: 09/26/2026